Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Villareal, D. T.
Right arrow Articles by Morris, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Villareal, D. T.
Right arrow Articles by Morris, J. C.
Related Collections
Right arrow Outcome research
Right arrow All Cognitive Disorders/Dementia
Right arrow Alzheimer's disease
Right arrow Cognitive aging

Neurology 2003;61:661-667
© 2003 American Academy of Neurology

Clinical outcomes of possible versus probable Alzheimer’s disease

Dennis T. Villareal, MD, Elizabeth Grant, PhD, J. Philip Miller, Martha Storandt, PhD, Daniel W. McKeel, MD and John C. Morris, MD

From the Division of Geriatrics and Gerontology (Dr. Villareal), Division of Biostatistics (Dr. Grant, J.P. Miller), Department of Psychology (Dr. Storandt), Departments of Neurology (Drs. Storandt and Morris) and Pathology and Immunology (Drs. McKeel and Morris), and the Alzheimer’s Disease Research Center, Washington University, St. Louis, MO.

Address correspondence and reprint requests to Dr. Dennis T. Villareal, Division of Geriatrics and Gerontology, Washington University School of Medicine, 4488 Forest Park Boulevard, St. Louis, MO 63108; e-mail: dvillare{at}im.wustl.edu

Objective: To determine whether Alzheimer’s disease (AD) associated with comorbidities or atypical features (possible AD) is marked by differences in clinical course and outcomes compared with uncomplicated AD (probable AD).

Methods: Annual evaluations were made of patients with AD, for up to 11 years. Six hundred forty subjects with AD were clinically classified into two groups: 1) possible AD (n = 208), and 2) probable AD (n = 432). Data on demographics, Mini-Mental State Examination (MMSE), Short Blessed Test (SBT), psychometric performance, and Clinical Dementia Rating (CDR) were collected at baseline. Kaplan–Meier survival curves and Cox proportional hazards models were conducted to evaluate whether possible AD would have different outcomes on dementia progression, nursing home placement, and death compared with probable AD.

Results: The possible AD group was slightly younger and less well educated than the probable AD group, but there were no group differences at baseline in MMSE, SBT, and CDR scores. Controlling for age and education, the possible AD group had poorer baseline psychometric performance (p = 0.022). There were no group differences, however, for rate of dementia progression, nursing home admission, and death.

Conclusions: Comorbidities and atypical features in this sample of patients with Alzheimer’s disease did not substantially affect dementia outcomes. The primary determinant of the clinical course of dementia in this sample was the presence of clinically diagnosed Alzheimer’s disease, independent of the presence or absence of comorbidities or atypical features. Therefore, patients with possible Alzheimer’s disease may be considered for inclusion in investigations of Alzheimer’s disease, including clinical trials, to improve the generalizability of the findings.




This article has been cited by other articles:


Home page
J Geriatr Psychiatry NeurolHome page
P. C. Harper and C. M. Roe
Thyroid Medication Use and Subsequent Development of Dementia of the Alzheimer Type
J Geriatr Psychiatry Neurol, March 1, 2010; 23(1): 63 - 69.
[Abstract] [PDF]


Home page
Clin Med ResHome page
W. S. Lim, M. S. Chong, and S. Sahadevan
Utility of the Clinical Dementia Rating in Asian Populations
Clin. Med. Res., March 1, 2007; 5(1): 61 - 70.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Fischer, S. Jungwirth, S. Zehetmayer, S. Weissgram, S. Hoenigschnabl, E. Gelpi, W. Krampla, and K. H. Tragl
Conversion from subtypes of mild cognitive impairment to Alzheimer dementia
Neurology, January 23, 2007; 68(4): 288 - 291.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. M. Williams, C. Xiong, J. C. Morris, and J. E. Galvin
Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease
Neurology, December 12, 2006; 67(11): 1935 - 1941.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Storandt, E. A. Grant, J. P. Miller, and J. C. Morris
Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI
Neurology, August 8, 2006; 67(3): 467 - 473.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. K. Johnson, J. C. Morris, and J. E. Galvin
Verbal and visuospatial deficits in dementia with Lewy bodies
Neurology, October 25, 2005; 65(8): 1232 - 1238.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. F. Fotenos, A. Z. Snyder, L. E. Girton, J. C. Morris, and R. L. Buckner
Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD
Neurology, March 22, 2005; 64(6): 1032 - 1039.
[Abstract] [Full Text] [PDF]